Trial intelligence / Profile preview

Therapeutic interventions on senescence markers after human kidney transplantation: does metformin meet expectations?

2012-003987-34Phase 4Terminated

Sponsor
UZ Leuven
Start
Jan 2013
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of metformin in Kidney allograft status (RTx) and Kidney allograft failure (2 arms), sponsored by UZ Leuven. Primary endpoint: Long-term graft histology. Started Jan 2013; status: terminated.

02

Drugs

metformin
03

Conditions

Kidney allograft status (RTx)Kidney allograft failure

Beyond the preview

Go deeper on 2012-003987-34.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2012-003987-34.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call